vs

Side-by-side financial comparison of Everus Construction Group, Inc. (ECG) and SONOCO PRODUCTS CO (SON). Click either name above to swap in a different company.

SONOCO PRODUCTS CO is the larger business by last-quarter revenue ($1.7B vs $1.0B, roughly 1.7× Everus Construction Group, Inc.). Everus Construction Group, Inc. runs the higher net margin — 5.5% vs 4.1%, a 1.4% gap on every dollar of revenue. On growth, Everus Construction Group, Inc. posted the faster year-over-year revenue change (33.2% vs -1.9%). Everus Construction Group, Inc. produced more free cash flow last quarter ($23.5M vs $-428.3B). Over the past eight quarters, Everus Construction Group, Inc.'s revenue compounded faster (27.1% CAGR vs 1.2%).

Sonoco Products Company is an American provider of diversified consumer packaging, industrial products, protective packaging, and packaging supply chain services and the world's largest producer of composite cans, tubes, and cores. The company was founded in 1889 as Southern Novelty Company with annualized net sales of approximately $7.3 billion. Sonoco has 19,900 employees in more than 335 operations in 33 countries, serving more than 85 nations. The company is headquartered in Hartsville, S...

ECG vs SON — Head-to-Head

Bigger by revenue
SON
SON
1.7× larger
SON
$1.7B
$1.0B
ECG
Growing faster (revenue YoY)
ECG
ECG
+35.1% gap
ECG
33.2%
-1.9%
SON
Higher net margin
ECG
ECG
1.4% more per $
ECG
5.5%
4.1%
SON
More free cash flow
ECG
ECG
$428.3B more FCF
ECG
$23.5M
$-428.3B
SON
Faster 2-yr revenue CAGR
ECG
ECG
Annualised
ECG
27.1%
1.2%
SON

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ECG
ECG
SON
SON
Revenue
$1.0B
$1.7B
Net Profit
$55.3M
$68.0M
Gross Margin
11.6%
20.6%
Operating Margin
6.8%
7.6%
Net Margin
5.5%
4.1%
Revenue YoY
33.2%
-1.9%
Net Profit YoY
60.4%
25.9%
EPS (diluted)
$1.09
$0.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ECG
ECG
SON
SON
Q1 26
$1.7B
Q4 25
$1.0B
$1.8B
Q3 25
$986.8M
$2.1B
Q2 25
$921.5M
$1.9B
Q1 25
$826.6M
$1.7B
Q4 24
$759.6M
Q3 24
$761.0M
$1.7B
Q2 24
$703.4M
$1.6B
Net Profit
ECG
ECG
SON
SON
Q1 26
$68.0M
Q4 25
$55.3M
$332.2M
Q3 25
$57.0M
$122.9M
Q2 25
$52.8M
$493.4M
Q1 25
$36.7M
$54.4M
Q4 24
$34.5M
Q3 24
$41.8M
$50.9M
Q2 24
$39.0M
$90.8M
Gross Margin
ECG
ECG
SON
SON
Q1 26
20.6%
Q4 25
11.6%
19.6%
Q3 25
12.6%
21.9%
Q2 25
13.0%
21.3%
Q1 25
11.2%
20.7%
Q4 24
11.4%
Q3 24
11.8%
21.4%
Q2 24
12.6%
22.0%
Operating Margin
ECG
ECG
SON
SON
Q1 26
7.6%
Q4 25
6.8%
29.4%
Q3 25
7.3%
9.1%
Q2 25
7.9%
9.2%
Q1 25
6.2%
7.4%
Q4 24
6.1%
Q3 24
7.1%
7.6%
Q2 24
7.3%
8.6%
Net Margin
ECG
ECG
SON
SON
Q1 26
4.1%
Q4 25
5.5%
18.8%
Q3 25
5.8%
5.8%
Q2 25
5.7%
25.8%
Q1 25
4.4%
3.2%
Q4 24
4.5%
Q3 24
5.5%
3.0%
Q2 24
5.5%
5.6%
EPS (diluted)
ECG
ECG
SON
SON
Q1 26
$0.68
Q4 25
$1.09
$3.33
Q3 25
$1.11
$1.23
Q2 25
$1.03
$4.96
Q1 25
$0.72
$0.55
Q4 24
$0.68
Q3 24
$0.82
$0.51
Q2 24
$0.76
$0.92

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ECG
ECG
SON
SON
Cash + ST InvestmentsLiquidity on hand
$224.5M
Total DebtLower is stronger
$281.5M
$3.5B
Stockholders' EquityBook value
$629.8M
$3.6B
Total Assets
$1.7B
$11.1B
Debt / EquityLower = less leverage
0.45×
0.97×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ECG
ECG
SON
SON
Q1 26
$224.5M
Q4 25
$378.4M
Q3 25
$244.9M
Q2 25
$329.8M
Q1 25
$181.8M
Q4 24
Q3 24
$553.0K
$1.9B
Q2 24
$140.2M
Total Debt
ECG
ECG
SON
SON
Q1 26
$3.5B
Q4 25
$281.5M
$3.8B
Q3 25
$285.1M
$3.8B
Q2 25
$288.6M
$5.0B
Q1 25
$292.1M
$5.0B
Q4 24
$295.6M
Q3 24
$4.3B
Q2 24
$2.5B
Stockholders' Equity
ECG
ECG
SON
SON
Q1 26
$3.6B
Q4 25
$629.8M
$3.6B
Q3 25
$573.0M
$3.3B
Q2 25
$514.4M
$3.2B
Q1 25
$460.2M
$2.4B
Q4 24
$422.6M
Q3 24
$453.3M
$2.5B
Q2 24
$490.0M
$2.4B
Total Assets
ECG
ECG
SON
SON
Q1 26
$11.1B
Q4 25
$1.7B
$11.2B
Q3 25
$1.6B
$11.7B
Q2 25
$1.5B
$12.0B
Q1 25
$1.4B
$12.7B
Q4 24
$1.3B
Q3 24
$1.3B
$9.0B
Q2 24
$7.2B
Debt / Equity
ECG
ECG
SON
SON
Q1 26
0.97×
Q4 25
0.45×
1.05×
Q3 25
0.50×
1.15×
Q2 25
0.56×
1.54×
Q1 25
0.63×
2.03×
Q4 24
0.70×
Q3 24
1.74×
Q2 24
1.04×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ECG
ECG
SON
SON
Operating Cash FlowLast quarter
$48.2M
Free Cash FlowOCF − Capex
$23.5M
$-428.3B
FCF MarginFCF / Revenue
2.3%
-25547.4%
Capex IntensityCapex / Revenue
2.4%
3600.5%
Cash ConversionOCF / Net Profit
0.87×
TTM Free Cash FlowTrailing 4 quarters
$90.0M
$-427.6B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ECG
ECG
SON
SON
Q1 26
Q4 25
$48.2M
$412.9M
Q3 25
$76.2M
$291.5M
Q2 25
$25.3M
$193.4M
Q1 25
$7.1M
$-208.1M
Q4 24
Q3 24
$78.9M
$162.1M
Q2 24
$109.3M
Free Cash Flow
ECG
ECG
SON
SON
Q1 26
$-428.3B
Q4 25
$23.5M
$322.3M
Q3 25
$65.7M
$225.6M
Q2 25
$12.3M
$98.6M
Q1 25
$-11.4M
$-300.8M
Q4 24
Q3 24
$60.9M
$70.5M
Q2 24
$16.0M
FCF Margin
ECG
ECG
SON
SON
Q1 26
-25547.4%
Q4 25
2.3%
18.2%
Q3 25
6.7%
10.6%
Q2 25
1.3%
5.2%
Q1 25
-1.4%
-17.6%
Q4 24
Q3 24
8.0%
4.2%
Q2 24
1.0%
Capex Intensity
ECG
ECG
SON
SON
Q1 26
3600.5%
Q4 25
2.4%
5.1%
Q3 25
1.1%
3.1%
Q2 25
1.4%
5.0%
Q1 25
2.2%
5.4%
Q4 24
Q3 24
2.4%
5.5%
Q2 24
5.7%
Cash Conversion
ECG
ECG
SON
SON
Q1 26
Q4 25
0.87×
1.24×
Q3 25
1.34×
2.37×
Q2 25
0.48×
0.39×
Q1 25
0.19×
-3.82×
Q4 24
Q3 24
1.89×
3.18×
Q2 24
1.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ECG
ECG

Commercial$594.5M59%
Utility$203.5M20%
Industrial$82.8M8%
Institutional$66.1M7%
Service And Other$28.4M3%
Transportation$24.2M2%
Renewables$19.8M2%

SON
SON

Consumer Packaging$1.1B65%
Industrial Paper Packaging$587.5M35%
All Other$55.1M3%

Related Comparisons